- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06868277
En global fase III-studie av Rilvegostomig eller pembrolizumab monoterapi for førstelinjebehandling av PD-L1-høy metastatisk ikke-småcellet lungekreft (ARTEMIDELung04)
En fase III, randomisert, dobbeltblind, multisenter, global studie av Rilvegostomig eller pembrolizumab monoterapi for første linjebehandling av pasienter med PD-L1-høy metastatisk ikke-småcellet lungekreft (Artemide-Lung04)
The purpose of ARTEMIDE-Lung04 is to assess the efficacy and safety of rilvegostomig compared with pembrolizumab monotherapy as 1L treatment in participants with mNSCLC and whose tumors express PD-L1.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This is a Phase III, two-arm, randomized, double-blind, global, multicenter study assessing the efficacy and safety of rilvegostomig compared to pembrolizumab as a 1L treatment for patients with mNSCLC whose tumors express PD-L1.
Studietype
Registrering (Antatt)
Fase
- Fase 3
Kontakter og plasseringer
Studiekontakt
- Navn: AstraZeneca Clinical Study Information Center
- Telefonnummer: 1-877-240-9479
- E-post: information.center@astrazeneca.com
Studiesteder
-
-
-
CABA, Argentina, 1425
- Rekruttering
- Research Site
-
Córdoba, Argentina, 5000
- Rekruttering
- Research Site
-
Pilar, Argentina, B1629AHJ
- Rekruttering
- Research Site
-
Rosario, Argentina, S2000CVB
- Rekruttering
- Research Site
-
Rosario, Argentina, 2000
- Rekruttering
- Research Site
-
Viedma, Argentina, R8500ACE
- Rekruttering
- Research Site
-
-
-
-
-
Hobart, Australia, 7000
- Tilbaketrukket
- Research Site
-
Woolloongabba, Australia, 4102
- Tilbaketrukket
- Research Site
-
-
-
-
-
Edegem, Belgia, 2650
- Rekruttering
- Research Site
-
Jette, Belgia, 1090
- Rekruttering
- Research Site
-
Libramont-Chevigny, Belgia, 6800
- Rekruttering
- Research Site
-
Liège, Belgia, 4000
- Rekruttering
- Research Site
-
Mechelen, Belgia, 2800
- Rekruttering
- Research Site
-
Roeselaere, Belgia, 8800
- Rekruttering
- Research Site
-
-
-
-
-
Blumenau, Brasil, 89010-340
- Rekruttering
- Research Site
-
Fortaleza, Brasil, 60336-550
- Rekruttering
- Research Site
-
Ijuí, Brasil, 98700-000
- Rekruttering
- Research Site
-
Itajaí, Brasil, 88301-220
- Rekruttering
- Research Site
-
Londrina, Brasil, 86015-520
- Rekruttering
- Research Site
-
Passo Fundo, Brasil, 99010-260
- Rekruttering
- Research Site
-
Porto Alegre, Brasil, 90035-903
- Rekruttering
- Research Site
-
Porto Alegre, Brasil, 90610-000
- Rekruttering
- Research Site
-
Porto Velho, Brasil, 76834-899
- Rekruttering
- Research Site
-
Salvador, Brasil, 41950-640
- Rekruttering
- Research Site
-
Salvador, Brasil, 41253-190
- Rekruttering
- Research Site
-
Santo André, Brasil, 09060-650
- Rekruttering
- Research Site
-
São Paulo, Brasil, 01246-000
- Rekruttering
- Research Site
-
São Paulo, Brasil, 04501-000
- Rekruttering
- Research Site
-
Teresina, Brasil, 64049-200
- Rekruttering
- Research Site
-
-
-
-
-
Burgas, Bulgaria, 8000
- Rekruttering
- Research Site
-
Panagyurishte, Bulgaria, 4500
- Rekruttering
- Research Site
-
Sofia, Bulgaria, 1407
- Rekruttering
- Research Site
-
Sofia, Bulgaria, 1756
- Rekruttering
- Research Site
-
Sofia, Bulgaria, 1618
- Rekruttering
- Research Site
-
Varna, Bulgaria, 9010
- Har ikke rekruttert ennå
- Research Site
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 1Z2
- Rekruttering
- Research Site
-
-
British Columbia
-
Kelowna, British Columbia, Canada, V1Y 5L3
- Har ikke rekruttert ennå
- Research Site
-
-
Ontario
-
Cambridge, Ontario, Canada, N1R 3G2
- Har ikke rekruttert ennå
- Research Site
-
Newmarket, Ontario, Canada, L3Y 2P9
- Har ikke rekruttert ennå
- Research Site
-
Toronto, Ontario, Canada, M4N 3M5
- Rekruttering
- Research Site
-
-
Quebec
-
Québec, Quebec, Canada, G1V 4G5
- Har ikke rekruttert ennå
- Research Site
-
Saint-Jérôme, Quebec, Canada, J7Z 5T3
- Har ikke rekruttert ennå
- Research Site
-
-
-
-
-
Conception, Chile, 4070196
- Rekruttering
- Research Site
-
Santiago, Chile, 7500653
- Rekruttering
- Research Site
-
Santiago, Chile, 8420383
- Rekruttering
- Research Site
-
Santiago, Chile, 7500713
- Rekruttering
- Research Site
-
-
-
-
-
Cali, Colombia, 760032
- Rekruttering
- Research Site
-
Floridablanca, Colombia, 680001
- Rekruttering
- Research Site
-
Medellín, Colombia, 050034
- Rekruttering
- Research Site
-
Valledupar, Colombia, 200001
- Rekruttering
- Research Site
-
-
-
-
-
San José, Costa Rica, 1000
- Rekruttering
- Research Site
-
San José, Costa Rica, 10108
- Rekruttering
- Research Site
-
San José Capital, Costa Rica, 1000
- Rekruttering
- Research Site
-
Santa Ana, Costa Rica, 10903
- Rekruttering
- Research Site
-
-
-
-
California
-
La Mesa, California, Forente stater, 91942
- Har ikke rekruttert ennå
- Research Site
-
Los Alamitos, California, Forente stater, 90720
- Har ikke rekruttert ennå
- Research Site
-
-
Delaware
-
Newark, Delaware, Forente stater, 19713
- Rekruttering
- Research Site
-
-
Florida
-
Bay Pines, Florida, Forente stater, 33744
- Rekruttering
- Research Site
-
Clearwater, Florida, Forente stater, 33756
- Rekruttering
- Research Site
-
Gainesville, Florida, Forente stater, 32610
- Rekruttering
- Research Site
-
St. Petersburg, Florida, Forente stater, 33705
- Rekruttering
- Research Site
-
-
Georgia
-
Marietta, Georgia, Forente stater, 30060
- Rekruttering
- Research Site
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60612
- Rekruttering
- Research Site
-
Decatur, Illinois, Forente stater, 62526
- Rekruttering
- Research Site
-
-
Iowa
-
Des Moines, Iowa, Forente stater, 50309
- Rekruttering
- Research Site
-
Waterloo, Iowa, Forente stater, 50702
- Har ikke rekruttert ennå
- Research Site
-
-
Kansas
-
Leawood, Kansas, Forente stater, 66209
- Rekruttering
- Research Site
-
-
Kentucky
-
Lexington, Kentucky, Forente stater, 40536
- Har ikke rekruttert ennå
- Research Site
-
Owensboro, Kentucky, Forente stater, 42303
- Rekruttering
- Research Site
-
-
Maryland
-
Bethesda, Maryland, Forente stater, 20817
- Rekruttering
- Research Site
-
Frederick, Maryland, Forente stater, 21702
- Rekruttering
- Research Site
-
Silver Spring, Maryland, Forente stater, 20910
- Rekruttering
- Research Site
-
Towson, Maryland, Forente stater, 21204
- Rekruttering
- Research Site
-
-
Michigan
-
Saginaw, Michigan, Forente stater, 48602
- Har ikke rekruttert ennå
- Research Site
-
-
Missouri
-
Bridgeton, Missouri, Forente stater, 63044
- Rekruttering
- Research Site
-
-
Nebraska
-
Lincoln, Nebraska, Forente stater, 68506
- Rekruttering
- Research Site
-
-
Nevada
-
Reno, Nevada, Forente stater, 89511
- Rekruttering
- Research Site
-
-
New Jersey
-
Paramus, New Jersey, Forente stater, 07652
- Har ikke rekruttert ennå
- Research Site
-
-
New York
-
Buffalo, New York, Forente stater, 14215
- Rekruttering
- Research Site
-
East Syracuse, New York, Forente stater, 13057
- Rekruttering
- Research Site
-
Fresh Meadows, New York, Forente stater, 11366
- Rekruttering
- Research Site
-
Rochester, New York, Forente stater, 14642
- Har ikke rekruttert ennå
- Research Site
-
Westbury, New York, Forente stater, 11590
- Rekruttering
- Research Site
-
-
Ohio
-
Canton, Ohio, Forente stater, 44718
- Har ikke rekruttert ennå
- Research Site
-
-
Pennsylvania
-
Fountain Hill, Pennsylvania, Forente stater, 18015
- Rekruttering
- Research Site
-
Kittanning, Pennsylvania, Forente stater, 16201
- Har ikke rekruttert ennå
- Research Site
-
Philadelphia, Pennsylvania, Forente stater, 19104
- Rekruttering
- Research Site
-
-
Texas
-
Round Rock, Texas, Forente stater, 78665
- Har ikke rekruttert ennå
- Research Site
-
-
Washington
-
Aberdeen, Washington, Forente stater, 98520
- Rekruttering
- Research Site
-
Renton, Washington, Forente stater, 98055
- Har ikke rekruttert ennå
- Research Site
-
-
West Virginia
-
Charleston, West Virginia, Forente stater, 25304
- Rekruttering
- Research Site
-
Morgantown, West Virginia, Forente stater, 26506
- Rekruttering
- Research Site
-
-
Wisconsin
-
Schofield, Wisconsin, Forente stater, 54476
- Har ikke rekruttert ennå
- Research Site
-
-
-
-
-
Angers, Frankrike, 49100
- Har ikke rekruttert ennå
- Research Site
-
Avignon, Frankrike, 84000
- Rekruttering
- Research Site
-
Boulogne-Billancourt, Frankrike, 92100
- Rekruttering
- Research Site
-
Caen, Frankrike, 14000
- Rekruttering
- Research Site
-
Chambéry, Frankrike, 73011
- Rekruttering
- Research Site
-
Dijon, Frankrike, 21000
- Rekruttering
- Research Site
-
La Tronche, Frankrike, 38700
- Rekruttering
- Research Site
-
Limoges, Frankrike, 87042
- Rekruttering
- Research Site
-
Nantes, Frankrike, 44093
- Rekruttering
- Research Site
-
Paris, Frankrike, 75020
- Rekruttering
- Research Site
-
Pau, Frankrike, 64046
- Rekruttering
- Research Site
-
St-Malo, Frankrike, 35403
- Rekruttering
- Research Site
-
Toulouse, Frankrike, 31300
- Har ikke rekruttert ennå
- Research Site
-
Tours, Frankrike, 37000
- Rekruttering
- Research Site
-
-
-
-
-
Tbilisi, Georgia, 0159
- Rekruttering
- Research Site
-
Tbilisi, Georgia, 0112
- Rekruttering
- Research Site
-
Tbilisi, Georgia, 160
- Rekruttering
- Research Site
-
Tbilisi, Georgia, 177
- Rekruttering
- Research Site
-
-
-
-
-
Athens, Hellas, 12462
- Rekruttering
- Research Site
-
Athens, Hellas, 11527
- Rekruttering
- Research Site
-
Athens, Hellas, 115 27
- Rekruttering
- Research Site
-
Larissa, Hellas, 411 10
- Rekruttering
- Research Site
-
Piraeus, Hellas, 185 37
- Rekruttering
- Research Site
-
Piraeus, Hellas, 185 47
- Rekruttering
- Research Site
-
Thessaloniki, Hellas, 56429
- Rekruttering
- Research Site
-
Thessaloniki, Hellas, 57001
- Rekruttering
- Research Site
-
Thessaloniki, Hellas, 55236
- Rekruttering
- Research Site
-
-
-
-
-
Cork, Irland, T12 DFK4
- Har ikke rekruttert ennå
- Research Site
-
Dublin, Irland, D08 NHY1
- Rekruttering
- Research Site
-
Dublin, Irland, D24 NR0A
- Rekruttering
- Research Site
-
Dublin, Irland, D07 R2WY
- Rekruttering
- Research Site
-
Dublin, Irland, D09 V2N0
- Rekruttering
- Research Site
-
Dublin, Irland, DO4YN63
- Rekruttering
- Research Site
-
Galway, Irland, H91 YR71
- Har ikke rekruttert ennå
- Research Site
-
-
-
-
-
Afula, Israel, 1834111
- Rekruttering
- Research Site
-
Beersheba, Israel, 8410101
- Rekruttering
- Research Site
-
Hadera, Israel, 38100
- Rekruttering
- Research Site
-
Haifa, Israel, 34362
- Rekruttering
- Research Site
-
Haifa, Israel, 91096
- Rekruttering
- Research Site
-
Jerusalem, Israel, 91031
- Rekruttering
- Research Site
-
Jerusalem, Israel, 91120
- Rekruttering
- Research Site
-
Ramat Gan, Israel, 52621
- Rekruttering
- Research Site
-
Tel Aviv, Israel, 64239
- Rekruttering
- Research Site
-
Tel Aviv, Israel, 69710
- Rekruttering
- Research Site
-
-
-
-
-
Candiolo, Italia, 10060
- Rekruttering
- Research Site
-
Lecco, Italia, 23900
- Rekruttering
- Research Site
-
Lucca, Italia, 55100
- Rekruttering
- Research Site
-
Meldola, Italia, 47014
- Rekruttering
- Research Site
-
Milan, Italia, 20132
- Rekruttering
- Research Site
-
Milan, Italia, 20133
- Har ikke rekruttert ennå
- Research Site
-
Naples, Italia, 80131
- Rekruttering
- Research Site
-
Peschiera del Garda, Italia, 37019
- Rekruttering
- Research Site
-
Pisa, Italia, 56126
- Rekruttering
- Research Site
-
Roma, Italia, 00144
- Rekruttering
- Research Site
-
Torrette Di Ancona, Italia, 60126
- Rekruttering
- Research Site
-
Udine, Italia, 33100
- Rekruttering
- Research Site
-
Verona, Italia, 37126
- Rekruttering
- Research Site
-
-
-
-
-
Akashi, Japan, 673-8558
- Rekruttering
- Research Site
-
Bunkyō City, Japan, 113-8603
- Rekruttering
- Research Site
-
Bunkyō City, Japan, 113-8677
- Rekruttering
- Research Site
-
Fukuoka, Japan, 812-8582
- Rekruttering
- Research Site
-
Fukuoka, Japan, 811-1395
- Rekruttering
- Research Site
-
Hamamatsu, Japan, 431-3192
- Rekruttering
- Research Site
-
Iwakuni-shi, Japan, 740-8510
- Rekruttering
- Research Site
-
Izumi-shi, Japan, 594-0073
- Rekruttering
- Research Site
-
Kashihara-shi, Japan, 634-8522
- Rekruttering
- Research Site
-
Kobe, Japan, 650-0046
- Rekruttering
- Research Site
-
Kurume-shi, Japan, 830-0011
- Rekruttering
- Research Site
-
Kyoto, Japan, 602-8566
- Rekruttering
- Research Site
-
Kōtoku, Japan, 135-8550
- Rekruttering
- Research Site
-
Matsuyama, Japan, 791-0280
- Rekruttering
- Research Site
-
Nankoku-shi, Japan, 783-8505
- Rekruttering
- Research Site
-
Niigata, Japan, 951-8566
- Rekruttering
- Research Site
-
Osaka, Japan, 534-0021
- Rekruttering
- Research Site
-
Sakaishi, Japan, 591-8555
- Rekruttering
- Research Site
-
Sayama, Japan, 589-8511
- Rekruttering
- Research Site
-
Sendai, Japan, 980-0873
- Rekruttering
- Research Site
-
Shinagawa-ku, Japan, 142-8666
- Rekruttering
- Research Site
-
Takarazuka-shi, Japan, 665-0827
- Rekruttering
- Research Site
-
Toon-Shi, Japan, 791-0295
- Rekruttering
- Research Site
-
Toyoake-shi, Japan, 470-1192
- Rekruttering
- Research Site
-
Toyonaka-shi, Japan, 560-8552
- Rekruttering
- Research Site
-
-
-
-
-
Baoding, Kina, 071000
- Har ikke rekruttert ennå
- Research Site
-
Beijing, Kina, 100142
- Har ikke rekruttert ennå
- Research Site
-
Beijing, Kina, 100021
- Rekruttering
- Research Site
-
Beijing, Kina, 101149
- Har ikke rekruttert ennå
- Research Site
-
Bengbu, Kina, 233004
- Rekruttering
- Research Site
-
Changchun, Kina, 130000
- Har ikke rekruttert ennå
- Research Site
-
Changchun, Kina, 130033
- Rekruttering
- Research Site
-
Changsha, Kina, 410013
- Har ikke rekruttert ennå
- Research Site
-
Changsha, Kina, 410008
- Har ikke rekruttert ennå
- Research Site
-
Chengdu, Kina, 610041
- Rekruttering
- Research Site
-
Chongqing, Kina, 400042
- Har ikke rekruttert ennå
- Research Site
-
Chongqing, Kina, 400030
- Har ikke rekruttert ennå
- Research Site
-
Fuzhou, Kina, 350001
- Rekruttering
- Research Site
-
Fuzhou, Kina, 350014
- Har ikke rekruttert ennå
- Research Site
-
Guangzhou, Kina, 510080
- Rekruttering
- Research Site
-
Haerbin, Kina, 150081
- Rekruttering
- Research Site
-
Hangzhou, Kina, 310022
- Har ikke rekruttert ennå
- Research Site
-
Hefei, Kina, 133500
- Rekruttering
- Research Site
-
Hefei, Kina, 230022
- Rekruttering
- Research Site
-
Jiamusi, Kina, 154007
- Rekruttering
- Research Site
-
Jinan, Kina, 250117
- Rekruttering
- Research Site
-
Langfang, Kina, 65699
- Rekruttering
- Research Site
-
Lanzhou, Kina, 730050
- Rekruttering
- Research Site
-
Linyi, Kina, 276001
- Rekruttering
- Research Site
-
Liuzhou, Kina, 545007
- Rekruttering
- Research Site
-
Nanchang, Kina, 330006
- Rekruttering
- Research Site
-
Nanchang, Kina, 330029
- Rekruttering
- Research Site
-
Nanjing, Kina, 210008
- Rekruttering
- Research Site
-
Nanjing, Kina, 210006
- Rekruttering
- Research Site
-
Nanning, Kina, 530021
- Rekruttering
- Research Site
-
Ningbo, Kina, 315010
- Rekruttering
- Research Site
-
Qingdao, Kina, 266071
- Rekruttering
- Research Site
-
Shanghai, Kina, 200092
- Har ikke rekruttert ennå
- Research Site
-
Shenyang, Kina, 110042
- Har ikke rekruttert ennå
- Research Site
-
Shenzhen, Kina, 518116
- Har ikke rekruttert ennå
- Research Site
-
Suzhou, Kina, 215004
- Rekruttering
- Research Site
-
Taiyuan, Kina, 030000
- Rekruttering
- Research Site
-
Wuhan, Kina, 430060
- Har ikke rekruttert ennå
- Research Site
-
Wuhan, Kina, 430030
- Har ikke rekruttert ennå
- Research Site
-
Xuzhou, Kina, 221002
- Rekruttering
- Research Site
-
Yantai, Kina, 264000
- Rekruttering
- Research Site
-
Zhengzhou, Kina, 450008
- Har ikke rekruttert ennå
- Research Site
-
-
-
-
-
George Town, Malaysia, 10350
- Rekruttering
- Research Site
-
Kota Bharu, Malaysia, 15586
- Rekruttering
- Research Site
-
Kuala Lumpur, Malaysia, 50586
- Rekruttering
- Research Site
-
Kuala Selangor, Malaysia, 62250
- Rekruttering
- Research Site
-
Perai, Malaysia, 13700
- Rekruttering
- Research Site
-
-
-
-
-
Alcabideche, Portugal, 2755-009
- Rekruttering
- Research Site
-
Braga, Portugal, 4710-243
- Rekruttering
- Research Site
-
Coimbra, Portugal, 3000-075
- Rekruttering
- Research Site
-
Lisbon, Portugal, 1400-038
- Rekruttering
- Research Site
-
Lisbon, Portugal, 1500-650
- Rekruttering
- Research Site
-
Lisbon, Portugal, 1769-001
- Rekruttering
- Research Site
-
Loures, Portugal, 2674-514
- Rekruttering
- Research Site
-
Matosinhos Municipality, Portugal, 4454-509
- Rekruttering
- Research Site
-
Porto, Portugal, 4200-319
- Rekruttering
- Research Site
-
Porto, Portugal, 4200-072
- Rekruttering
- Research Site
-
Porto, Portugal, 4100-180
- Rekruttering
- Research Site
-
-
-
-
-
Bucharest, Romania, 022328
- Rekruttering
- Research Site
-
Bucharest, Romania, 013812
- Rekruttering
- Research Site
-
Bucharest, Romania, 30167
- Rekruttering
- Research Site
-
Bucharest, Romania, 010626
- Rekruttering
- Research Site
-
Craiova, Romania, 200385
- Rekruttering
- Research Site
-
Craiova, Romania, 200542
- Rekruttering
- Research Site
-
Iași, Romania, 700106
- Har ikke rekruttert ennå
- Research Site
-
Otopeni, Romania, 075100
- Rekruttering
- Research Site
-
Piteşti, Romania, 110283
- Rekruttering
- Research Site
-
Sibiu, Romania, 550253
- Rekruttering
- Research Site
-
Timișoara, Romania, 300239
- Rekruttering
- Research Site
-
-
-
-
-
Badajoz, Spania, 06080
- Rekruttering
- Research Site
-
Badalona, Spania, 8916
- Rekruttering
- Research Site
-
Barcelona, Spania, 08028
- Rekruttering
- Research Site
-
Castellon, Spania, 12002
- Rekruttering
- Research Site
-
Granada, Spania, 18016
- Har ikke rekruttert ennå
- Research Site
-
Jaén, Spania, 23007
- Har ikke rekruttert ennå
- Research Site
-
Lugo, Spania, 27003
- Rekruttering
- Research Site
-
Madrid, Spania, 28050
- Har ikke rekruttert ennå
- Research Site
-
Madrid, Spania, 28040
- Rekruttering
- Research Site
-
Madrid, Spania, 28041
- Har ikke rekruttert ennå
- Research Site
-
Málaga, Spania, 29010
- Rekruttering
- Research Site
-
Oviedo, Spania, 33006
- Rekruttering
- Research Site
-
Palma de Mallorca, Spania, 07198
- Rekruttering
- Research Site
-
Valencia, Spania, 46015
- Rekruttering
- Research Site
-
Vigo (Pontevedra), Spania, 36312
- Rekruttering
- Research Site
-
Zaragoza, Spania, 50009
- Rekruttering
- Research Site
-
-
-
-
-
Blackpool, Storbritannia, FY3 8NR
- Rekruttering
- Research Site
-
Glasgow, Storbritannia, G12 0YN
- Rekruttering
- Research Site
-
Guildford, Storbritannia, GU2 7XX
- Rekruttering
- Research Site
-
Hull, Storbritannia, HU16 5JQ
- Rekruttering
- Research Site
-
Northwood, Storbritannia, HA6 2RN
- Rekruttering
- Research Site
-
Oxford, Storbritannia, OX4 6LB
- Rekruttering
- Research Site
-
-
-
-
-
Lausanne, Sveits, 1011
- Rekruttering
- Research Site
-
-
-
-
-
Jinju, Sør -Korea, 52727
- Rekruttering
- Research Site
-
Seoul, Sør -Korea, 5505
- Rekruttering
- Research Site
-
Seoul, Sør -Korea, 135-710
- Rekruttering
- Research Site
-
-
-
-
-
Ankara, Tyrkia (Türkiye), 06010
- Rekruttering
- Research Site
-
Bakırköy, Tyrkia (Türkiye), 34147
- Rekruttering
- Research Site
-
Küçükçekmece, Tyrkia (Türkiye), 34295
- Rekruttering
- Research Site
-
Yüreğir, Tyrkia (Türkiye), 01240
- Rekruttering
- Research Site
-
Çankaya, Tyrkia (Türkiye), 06680
- Rekruttering
- Research Site
-
İzmit, Tyrkia (Türkiye), 41380
- Rekruttering
- Research Site
-
-
-
-
-
Amberg, Tyskland, 92224
- Rekruttering
- Research Site
-
Augsburg, by, Tyskland, 86156
- Har ikke rekruttert ennå
- Research Site
-
Bad Saarow, Tyskland, 15526
- Rekruttering
- Research Site
-
Berlin, Tyskland, 12351
- Rekruttering
- Research Site
-
Berlin, Tyskland, 13359
- Rekruttering
- Research Site
-
Bonn, Tyskland, 53127
- Rekruttering
- Research Site
-
Braunschweig, Tyskland, 38114
- Rekruttering
- Research Site
-
Essen, Tyskland, 45147
- Rekruttering
- Research Site
-
Flensburg, Tyskland, 24939
- Rekruttering
- Research Site
-
Frankfurt am Main, Tyskland, 60431
- Har ikke rekruttert ennå
- Research Site
-
Hamburg, Tyskland, 21075
- Rekruttering
- Research Site
-
Heidelberg, Tyskland, 69126
- Rekruttering
- Research Site
-
Heilbronn, Tyskland, 74078
- Har ikke rekruttert ennå
- Research Site
-
Immenhausen, Tyskland, 34376
- Rekruttering
- Research Site
-
Koblenz, Tyskland, 56073
- Rekruttering
- Research Site
-
Leipzig, Tyskland, 04103
- Har ikke rekruttert ennå
- Research Site
-
München, Tyskland, 80336
- Har ikke rekruttert ennå
- Research Site
-
Neuss, Tyskland, 41462
- Har ikke rekruttert ennå
- Research Site
-
Offenbach, Tyskland, 63069
- Har ikke rekruttert ennå
- Research Site
-
Oldenburg, Tyskland, 26121
- Rekruttering
- Research Site
-
Remscheid, Tyskland, 42859
- Har ikke rekruttert ennå
- Research Site
-
Rotenburg (Wümme), Tyskland, 27356
- Har ikke rekruttert ennå
- Research Site
-
Schweinfurt, Tyskland, 97421
- Rekruttering
- Research Site
-
Trier, Tyskland, 54292
- Har ikke rekruttert ennå
- Research Site
-
Velbert, Tyskland, 42551
- Rekruttering
- Research Site
-
Wuppertal, Tyskland, 42283
- Rekruttering
- Research Site
-
Würselen, Tyskland, 52146
- Har ikke rekruttert ennå
- Research Site
-
Würzburg, Tyskland, 97080
- Rekruttering
- Research Site
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Histologically or cytologically documented NSCLC (non small lung cancer), including all histological subtypes.
- Stage IV mNSCLC (metastatic non-small cell lung cancer) (based on the American Joint Committee on Cancer Edition 8) not amenable to curative treatment.
- Absence of sensitizing EGFR (epidermal growth factor) mutations and ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) rearrangements. Negative assay result is required for all non-squamous histology subtypes.
- Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any other actionable driver oncogenes for which there are locally approved targeted 1L (first line) therapies.
- WHO (World Health Organization)/ECOG (Eastern Cooperative Oncology Group) performance status of 0 or 1, with no deterioration over the previous 2 weeks prior to baseline at screening and prior to randomization.
- Minimum life expectancy of 12 weeks.
- Provision of acceptable tumor sample for the central testing prior to randomization.
- At least one lesion not previously irradiated that qualifies as a RECIST 1.1 (Response Evaluation Criteria in Solid Tumors, Version 1.1) TL (target lesion) at baseline and can be accurately measured at baseline as ≥ 10 mm in the longest diameter (except lymph nodes, which must have short axis ≥ 15 mm) with CT (computed tomography) or MRI (magnetic resonance imaging) and is suitable for accurate repeated measurements.
- Adequate organ and bone marrow function
Exclusion Criteria:
- As judged by the investigator, any severe or uncontrolled systemic diseases, makes it undesirable for the participant to participate in the study or that would jeopardize compliance with the protocol.
- History of organ transplant.
- Active or prior documented autoimmune or inflammatory disorders requiring chronic treatment with steroids or other immunosuppressive treatment.
- History of another primary malignancy except for malignancy treated with curative intent with no known active disease ≥ 2 years before the first dose of study intervention and of low potential risk for recurrence.
- Presence of small cell and neuroendocrine histology components.
- Brain metastases unless asymptomatic, stable, and not requiring steroids or anticonvulsants for at least 4 weeks prior to start of study intervention.
- Active primary immunodeficiency/active infectious disease(s)
- Active tuberculosis infection
- Any prior systemic therapy received for advanced or mNSCLC (metastatic non-small cell lung cancer).
- Any prior exposure to an anti-TIGIT (T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain) therapy or any other anticancer therapy targeting immune-regulatory receptors or mechanisms.
- Any prior treatment with an anti-PD-1 (programmed cell death protein 1) or anti-PD-L1 (anti-programmed death-ligand 1) agent.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Arm A
Drug: rilvegostomig |
Administered intravenously (IV) on Day 1 of each 21-day cycle
Andre navn:
|
|
Aktiv komparator: Arm B
Drug: Pembrolizumab |
Administered intravenously (IV) on Day 1 of each 21-day cycle
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall Survival (OS)
Tidsramme: Up to approximately 5 years
|
OS is defined as the time from randomization until the date of death due to any cause. |
Up to approximately 5 years
|
|
Progression-Free Survival (PFS)
Tidsramme: Up to approximately 5 years
|
PFS is defined as the time from randomization until radiological progression per RECIST 1.1 or death due to any cause (in the absence of progression). |
Up to approximately 5 years
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Landmark Overall Survival (OS) rates
Tidsramme: Up to approximately 5 years
|
OS is defined as the time from randomization until the date of death due to any cause. |
Up to approximately 5 years
|
|
Landmark Progression-Free Survival (PFS) rates
Tidsramme: Up to approximately 5 years
|
PFS is defined as the time from randomization until radiological progression per RECIST 1.1 or death due to any cause (in the absence of progression). |
Up to approximately 5 years
|
|
Objective Response Rate (ORR)
Tidsramme: Up to approximately 5 years
|
ORR is defined as the proportion of participants who have a confirmed CR or confirmed PR, using RECIST 1.1. |
Up to approximately 5 years
|
|
Duration of Response (DoR)
Tidsramme: Up to approximately 5 years
|
DoR is defined as the time from the date of first documented response until the date of documented progression using RECIST 1.1 or death due to any cause (in the absence of progression). |
Up to approximately 5 years
|
|
Time to second progression or death (PFS2)
Tidsramme: Up to approximately 5 years
|
PFS2 is defined as the time from randomization until the earliest of the progression event (following the initial investigator-assessed progression event), after the start of the first subsequent therapy, or death from any cause, whichever occurs first. |
Up to approximately 5 years
|
|
Pharmakokinetics (PK) of rilvegostomig
Tidsramme: Up to approximately 5 years
|
Concentration of rilvegostomig in serum |
Up to approximately 5 years
|
|
Immunogenicity of rilvegostomig
Tidsramme: Up to approximately 5 years
|
Presence of antidrug antibodies (ADAs), titer, and neutralizing antibodies for rilvegostomig. |
Up to approximately 5 years
|
|
Patient-reported physical functioning
Tidsramme: Up to approximately 5 years
|
Proportion of participants with maintained or improved physical functioning as measured by Patient-Reported Outcomes Measurement Information System Physical Function - Short Form 8c - 7 day (PROMIS PF-SF 8c - 7 day) at each time point. |
Up to approximately 5 years
|
|
Patient-reported global health status (GHS)/quality of life (QoL)
Tidsramme: Up to approximately 5 years
|
Time to deterioration (TTD) of GHS/QoL as measured by the European Organization for Research and Treatment of Cancer Item Library 172 (EORTC IL172). TTD is defined as time from randomization to the date of first deterioration. |
Up to approximately 5 years
|
|
Patient-reported lung cancer symptoms of non-small cell lung cancer (NSCLC)
Tidsramme: Up to approximately 5 years
|
Time to deterioration (TTD) in pulmonary symptoms as measured by the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ). TTD is defined as time from randomization to the date of first deterioration. |
Up to approximately 5 years
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- D702GC00001
- 2024-517780-24-00 (Registeridentifikator: CTIS (EU))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Qualified researchers can request access to anonymized individual participant-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All requests will be evaluated as per the AZ disclosure commitment:
https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.
IPD-delingstidsramme
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Tilgangskriterier for IPD-deling
When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .